This is a Validated Antibody Database (VAD) review about human FZD4, based on 3 published articles (read how Labome selects the articles), using FZD4 antibody in all methods. It is aimed to help Labome visitors find the most suited FZD4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FZD4 synonym: CD344; EVR1; FEVR; FZD4S; Fz-4; Fz4; FzE4; GPCR; hFz4; frizzled-4; WNT receptor frizzled-4; frizzled 4, seven transmembrane spanning receptor; frizzled family receptor 4; frizzled homolog 4

BioLegend
mouse monoclonal (CH3A4A7)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend FZD4 antibody (BioLegen d, 326606) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Abcam
goat polyclonal
  • western blot; human; 1:1000; fig 6
In order to identify miRNAs that contribute to prostate cancer, Abcam FZD4 antibody (Abcam, ab77724) was used in western blot on human samples at 1:1000 (fig 6). Oncogene (2014) ncbi
R&D Systems
rat monoclonal (145901)
  • flow cytometry; human
R&D Systems FZD4 antibody (R & D Systems, 145901) was used in flow cytometry on human samples . Mol Cell Biol (2015) ncbi
Articles Reviewed
  1. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  2. Tsukiyama T, Fukui A, Terai S, Fujioka Y, Shinada K, Takahashi H, et al. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling. Mol Cell Biol. 2015;35:2007-23 pubmed publisher
  3. Formosa A, Markert E, Lena A, Italiano D, Finazzi Agrò E, Levine A, et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33:5173-82 pubmed publisher